The future of AI drug discovery & development in immunology and GPCR research
pharmaphorum
SEPTEMBER 16, 2022
Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. A notable issue with clinical trials is the homogeneity of the patient database. What, then, is the solution? About the interviewee.
Let's personalize your content